38
Views
14
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Effects of Antimicrobial Prophylaxis on Asymptomatic Bacteriuria and Predictors of Failure in Patients with Multiple Sclerosis

Pages 36-43 | Published online: 18 Jul 2013
 

Abstract

We studied the effects of antimicrobial prophylaxis and possible predictors of failure in multiple sclerosis patients with bacteriuria and bladder dysfunction. Patients were categorized into 3 groups, according to post-voided residual urine volume (PVR): patients with indications for self intermittent catheterization (SIC) who elected (Group A, n=39) or not (Group b, n=53) to use SIC and patients with no indication for SIC (Group C, n=75). In group A, 90% of patients developed bacteriuria after SIC. Rates of bacteriuria in groups b and C were significantly lower (34% and 24%, respectively, all p<0.001). prophylaxis failed in 31% and 22% of patients in groups A and b, respectively whereas all group C patients responded to prophylaxis. Symptomatic urinary tract infection was observed only in 14% of group A patients. Significant predictors of prophylaxis failure were an expanded disability status scale (EDSS) score ≥6 (p≤0.05), a high PVR (p≤0.075) and resistance to prophylaxis regimen (p≤0.007). SIC did not have a significant association with prophylaxis failure. In multivariate analysis only a higher EDSS score (≥6) predicted prophylaxis failure (p=0.019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.